Register for our free email digests:
ThromboGenics teams up with Eleven Biotherapeutics for back-of-the-eye disease treatment
- Large Molecule
- Includes Royalty or Profit Split Information
- Intra-Biotech Deal
- R+D and Marketing-Licensing
- Includes Contract
You must sign in to use this functionality
All set! This article has been sent to firstname.lastname@example.org.
All fields are required. For multiple recipients, separate email addresses with a semicolon.